glp 1 trials clinical trial Another milestone in the evolution of GLP-1-based diabetes therapies GLP-1 Receptor Agonists as Treatments – GLP-1 Receptor Agonists and Research

This represents a critical evolution in obesity management, particularly for the growing population of GLP-1 non-responders requiring personalized treatment approaches

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines key variants in GLP1R, GIPR, FTO, and MC4R genes that influence peptide signaling pathways relevant to GLP-1 therapy

Mastaitis JW, et al

Four targeted steps

Nature 521 , 436444 (2015)

ACTL6A, a member of SWI/SNF complex, has been reported to be involved in various cancers, including squamous cell carcinoma 11,14,52 , colon cancer 12 , osteosarcoma 53 , glioma 10,54 , and hepatocellular carcinoma 13